Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 20NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 3Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Renal Insufficiency, Chronic 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Carcinoma, Medullary 1

Interventions

Radiotherapy 34Gemcitabine 24Docetaxel 24bicalutamide 23Goserelin 21Paclitaxel 19Cisplatin 19Doxorubicin 18Carboplatin 18Flutamide 17Leuprolide 16Radiotherapy, Conformal 13Etoposide 13Filgrastim 12Prednisone 11Gene Expression Profiling 11Gonadotropin-Releasing Hormone 10Radiotherapy, Intensity-Modulated 9Vincristine 8Vinblastine 8Triptorelin Pamoate 8Magnetic Resonance Spectroscopy 8Cyclophosphamide 8Buserelin 8Androgen Antagonists 8Surgical Procedures, Operative 7Radiation 7Polymerase Chain Reaction 7Methotrexate 7Estramustine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Practice Guidelines as Topic × Genitourinary × Clear all
NCT04467021 2026-05-06

Cancer and Blood Pressure Management, CARISMA Study

Eastern Cooperative Oncology Group

Phase NA Active not recruiting
61 enrolled
Genitourinary

Carcinoma, Renal Cell, Cardiovascular Diseases, Carcinoma, Medullary, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡